11β-hydroxylase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency historical perspective|Historical Perspective]]== | ==[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency historical perspective|Historical Perspective]]== | ||
==[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency classification|Classification]]== | |||
==[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency pathophysiology|Pathophysiology]]== | ==[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency pathophysiology|Pathophysiology]]== | ||
Revision as of 19:56, 25 January 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies